Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.89%
#2 PondCoin PondCoin +38.02%
#3 Pons Pons +37.83%
#4 Purr Purr +31.45%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.06%
#6 TENDIES TENDIES +29.61%
#7 Starpower Starpower +25.92%
#8 StonkBroker StonkBroker +25.10%
#9 SkyAI SkyAI +24.61%
#10 Magma Finance Magma Finance +23.96%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Rang in Aktien #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Aktienkurs
$152.40
Marktkapitalisierung
$376.40B
Veränderung (1 Tag)
12.48%
Veränderung (1 Jahr)
79.44%
Land
US
Handel Merck & Co., Inc. (MRK)

Kategorie

Healthcare
Anzahl der ausstehenden Aktien von Merck & Co., Inc. (MRK)
Anzahl der ausstehenden Aktien zum June 2026: 0.00
Laut den neuesten Finanzberichten und dem Aktienkurs von Merck & Co., Inc. beträgt die aktuelle Anzahl der ausstehenden Aktien 0.00. Am Ende von December 2024 hatte das Unternehmen 2.53B ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Merck & Co., Inc. (MRK) von 2000 bis 2026
Ausstehende Aktien am Ende jedes Jahres
Jahr Ausstehende Aktien ändert
2026 (TTM) 0.00 -100.00%
2025 2.51B -0.97%
2024 2.53B -2.88%
2023 2.61B 2.97%
2022 2.53B 0.08%
2021 2.53B 0.00%
2020 2.53B -1.36%
2019 2.57B -1.06%
2018 2.59B -3.86%
2017 2.70B -1.90%
2016 2.75B -1.16%
2015 2.78B -2.01%
2014 2.84B -3.05%
2013 2.93B -3.27%
2012 3.03B -0.47%
2011 3.04B -1.75%
2010 3.10B 46.79%
2009 2.11B -1.29%
2008 2.14B -1.59%
2007 2.17B -0.33%
2006 2.18B -0.88%
2005 2.20B -0.99%
2004 2.22B -0.79%
2003 2.24B -0.92%
2002 2.26B -1.35%
2001 2.29B -0.81%
2000 2.31B 0.00%
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
Unternehmen Ausstehende Aktien Unterschied Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.44B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M -
CH
Novartis AG Novartis AG
Novartis AG
NOVN.SW
 1.91B -
CH